This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Menopause Treatment Market

Market Insights on Menopause Treatment covering sales outlook, demand forecast & up-to-date key trends

Menopause Treatment Market By Product, Route of Administration, Distribution Channel & Region | Forecast 2022 to 2032

Menopause Treatment Market Snapshot (2022 to 2032)

[272 Pages Report] The global menopause treatment market is expected to enjoy a valuation of US$ 13.3 Billion by the end of the year 2022, and further expand at a CAGR of 5.5% to reach a valuation of ~US$ 22.9 Billion by the year 2032. According to a recent study by Future Market Insights, hormone therapy, by product, is leading the market with a share of about 59.7% in the year 2021, within the global market.

Market Outlook:

Data Points

Market Insights

Market Value 2022

US$ 21.7 Billion

Market Value 2032

US$ 22.9 Billion

CAGR 2022-2032

5.6%

Market Share of Top 5 Countries

55.5%

Key Market Players

Eli Lilly and Company, Merck KGaA, Novartis AG, Bayer AG, Pfizer, Inc., Novo Nordisk, Ascend Therapeutics, Mylan N.V. [Viatris], Cipla, Inc., Glenmark Pharmaceuticals Ltd., MenoGeniX, Perrigo Pharma International D.A.C., Ausio Pharmaceuticals, LLC, EndoCeutics, Inc., and Radius Health, Inc.

Menopause is a natural biological process due to the decline of reproductive hormones. This marks the end of the menstrual cycle in a woman’s life. It generally occurs at the age of 40s or 50s. Every woman experiences these menopause symptoms in a different way. Estrogen levels decrease throughout menopause. These signs and symptoms include abnormal menstrual cycles, night sweats, vaginal dryness, hot flashes, difficulty sleeping, mood swings, and others.

Hormone Replacement Therapy is the most successful treatment for menopause symptoms. Hormone replacement therapy (HRT), also known as menopausal hormone therapy and oestrogen replacement therapy, can address both growth hormone and thyroid hormone deficiencies. HRT replaces depleted hormone levels as menopausal women experience them.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Menopause Treatment Market from 2017 to 2021 Vs Market Outlook for 2022 to 2032

The global menopause market is valued at US$ 17.2 Billion out of which the menopause treatment market consists of a share of 73.5%.

The menopause market is not only about therapy but also menstrual wellness and care. A majority of supplements available provide wellness and care. Although over-the-counter medication holds a more significant chunk of the market due to its use in therapy.

The global postmenopausal female population is increasing. According to the World Health Organization 2022, women over the age of 50 and more accounted for 26% of all women and girls worldwide in 2021. This was an increase from 22% ten years ago.

Women are also living longer lives. On average, a woman turning 60 in 2019 can expect to live another 21 years.

A majority of the female population faces menopause, osteoporosis, growth hormone deficiency, thyroid, and cancer. Hot flashes, vaginal dryness, mood changes, night sweats, and bone loss are similar patterns and trends observed. Early menopause and hysterectomy are also procedures or behaviors that contribute to the event. This creates a scope for the manufacturers to work on better drug formulations, which can address the problems of patients suffering from menopause along with underlying chronic diseases.

Evenity (romosozumab-aqqg) has been given approval by the U.S. Food and Drug Administration to manage osteoporosis among postmenopausal women who are at severe risk of breaking a bone (fracture). These are women who have a record of osteoporotic fractures, have several fracture risk factors, or have tried and failed to respond to various osteoporosis treatments. Women at risk of osteoporosis are benefitted from such therapies, and companies come up with novel products and regulatory approvals on drugs. Thus, the market will gain traction, as more post-menopausal women will adopt these therapies.

Smoking, side effects of chemotherapy or radiation, ovarian cyst, and unhealthy lifestyle are assumptions that create and trigger the associated symptoms of menopause. Disruptive technology in drug development and delivery in menopause treatment, with therapy affordability, is expected to spur industry growth.

Thus, owing to the aforementioned factors, the global menopause treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2022 to 2032.

Menopause Treatment Market Download Report Brochure

What are the Key Opportunities for the Manufacturers operating in the Menopause Treatment Market?

An increase in the number of menopausal drugs in the drug development pipeline of various vital manufacturers is one of the biggest opportunities for the growth of the menopause treatment market. This also includes specific and innovative drugs, which focus on reducing side effects and providing better efficacy.

For instance, Fuji Pharma Co., Ltd. has a natural progesterone drug (FSN-011-01) in its pipeline and has submitted an application for marketing approval to the Ministry of Health, Labour and Welfare, Japan.

The first and only body-identical hormone replacement therapy (HRT) for oestrogen insufficiency symptoms in postmenopausal women with an intact uterus and at least a year since their last period, Bijuva, also known as Bijuve in the UK, which includes estradiol and progesterone in a single daily oral capsule.

The presence of natural and herbal treatment is also an option that makes women feel secure if the traditional treatment method fails.

Government initiatives to create awareness about women’s health, especially menopause, could be an opportunity to grow the menopause treatment market.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Demand for Menopause Treatment?

The risks associated with menopausal hormone therapies can hamper the menopause treatment market growth. Menopausal hormone therapy or postmenopausal hormone therapy involves treatment with either estrogen alone or estrogen in combination with progestin.

Hormone therapy carries various hazards, including the possibility of stroke, blood clots, heart problems, and breast cancer, according to the FDA. The FDA also recommends that hormone therapy be taken at the lowest effective dose for the shortest amount of time.

Strict regulatory approvals can be a restraining factor for the menopausal drugs market. The approval process for the drugs is quite time-consuming and strict due to the safety and efficacy profiles associated with the drugs.

Country-wise Insights

What Makes the US a Highly Lucrative Market for Menopause Treatment?

The US dominates the global menopause treatment market with a total global market share of about 18.7% in 2021 and is expected to continue to experience the same growth throughout the forecast period with a CAGR growth rate of nearly 5.8%.

Due to a stronger emphasis on research and development, the American pharmaceutical industry has advanced significantly during the past few decades. The advanced medical environment in the country has resulted in the world's lowest cancer mortality rates, a life expectancy for people over 80 that is actually higher compared to other regions, and reduced heart attack and stroke death rates than those in similar countries. This can fundamentally be attributed to the country’s economy.

According to the American Medical Association 2021 study, the average age of natural menopause grew by 1.5 years over the previous six decades, whereas the average reproductive life duration increased by 2.1 years.

As a result of the aforementioned causes, demand for menopause treatment will continue to rise in the United States, boosting the overall value of the menopause treatment market.

What is the Outlook of China in the Menopause Treatment Market?

China is one of the leading manufacturers in the menopause treatment market. China held a global market share of 11.4% and is anticipated to grow at a rapid pace over the forecast period due to rising healthcare facilities in the region along with prominent manufacturers.

China is one of the most densely inhabited countries. The growing elderly population and the need for healthcare services present an opportunity for the menopause treatment market to flourish in countries such as China.

The cost of production is lower in China. Multinational corporations are eyeing China for the manufacturing benefits it provides, and they are collaborating with the Chinese raw material manufacturer to compete with the primary competitors.

What Makes India a Large Market for Menopause Treatment?

India is set to exhibit growth at a CAGR of nearly 5.9% in the global menopause treatment market during the forecast period. The establishment of society and institutes focusing on creating general awareness and eliminating taboos related to menopause is growing in India. According to National Family Health Survey 2021, in India, 35.3% of menopausal women experienced induced menopause.

Contract manufacturing organizations (CMO) and pharmaceutical industries in India have recently drawn significant investment from global private equity investors owing to favorable government policies and a growing generic pharmaceuticals market. More companies are interested and are investing in CMOs as India displays strides in technology, development, infrastructure, and product innovations.

The market is also being driven by the nation's access to manufacturing facilities and strong levels of Research and Development activity. Researchers are working together to develop effective, multipurpose menopause treatment.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Category-wise Insights

Which Menopause Treatment Product is Driving Market Growth?

Hormone therapy is expected to present high growth at a CAGR of 5.6% by the end of the forecast period, holding a market share of about 59.7% in the global market in 2021. The most effective and widely accepted method of treating menopausal heat flashes is estrogen medication and thus accelerating market growth. Hormone therapy is widely accepted for a long period of time because of its efficiency and improvement that it brings to women’s health.

Which Route of Administration is dominating the Menopause Treatment Market Globally?

The oral route of administration is widely accepted and used in the menopause treatment market and held a market share of around 64.0% in 2021. This segment is further expected to grow at a CAGR of 5.7% over the forecast duration. Oral drugs are one of the easiest, most affordable, most durable, and most portable. The contamination rate is also the least. This makes the oral route of administration more lucrative. The oral mode of administration is the most accessible, cost-effective, and widely used mode of medication administration.

Which Distribution Channel Benefits the Most from the Sales of Menopause Treatment Products Globally?

Retail sales held the highest market share with a revenue of around US$ 5.6 Billion during the year 2021. The easy availability and additional benefits such as ease of locations and delivery of medications make retail sales the most lucrative segment of the overall menopause treatment market. Moreover, greater ease of accessibility to hormone therapies introduces greater adoption of menopause treatment, thus propelling market sales.

Competitive Landscape

The total market is fragmented, with large and notable rivals in the menopausal treatment production sphere. These companies are employing techniques such as mergers and acquisitions, partnerships and collaborations, and new product offerings to match consumer demand and expand their client base.

Instances of key developmental strategies by the industry players in the menopause treatment market are given below:

  • In 2017, Mylan N.V. US introduced Estradiol Vaginal Cream USP, 0.01%, the very first generic form of Allergan's Estrace® cream. The FDA granted Mylan final approval for its abbreviated new drug application (ANDA) for this medicine, which was indicated for the treatment of vulvar and vaginal atrophy.
  • Myovant Sciences and Pfizer Inc. confirmed in May 2021 that the US Food and Drug Administration (FDA) had authorized MYFEMBREE®, the first once-daily medication for excessive menstrual bleeding linked with uterine fibroids in premenopausal women.

Similarly, recent developments related to companies manufacturing menopause treatment products, have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as per Menopause Treatment Industry Analysis

Attribute

Details

Historical Data Available for

2017 to 2021

Forecast Period

2022 to 2032

Market Analysis

US$ Million for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

US, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa

Key Market Segments Covered

Product, Route of Administration, Distribution Channel, and Region

Key Companies Profiled

  • Eli Lilly and Company
  • Merck KGaA
  • Novartis AG
  • Bayers AG
  • Pfizer, Inc.
  • Novo Nordisk
  • Ascend Therapeutics
  • Mylan N.V. [Viatris]
  • Cipla, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • MenoGeniX
  • Perrigo Pharma International D.A.C.
  • Ausio Pharmaceuticals, LLC
  • EndoCeutics, Inc.
  • Radius Health, Inc.

Pricing

Available upon Request

Key Market Segments Covered in Menopause Treatment Industry Research

By Product:

  • Hormone Therapy
    • Combination
    • Tibolone
    • Progestin-Only Medicines
    • Estrogen-Only Medicines
  • Non-Hormonal Therapy
    • Gabapentinoids
    • Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
    • Selective Serotonin Reuptake Inhibitors (SSRI)
    • Others

By Route of Administration:

  • Topical
  • Injectable
  • Oral

By Distribution Channel:

  • Institutional Sales
    • Hospitals
    • Specialty Clinics
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Supermarkets/ Hypermarkets
  • Online Sales

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global menopause treatment market is estimated to be worth US$ 13.3 Billion in 2022 and is set to expand 1.7X over the next ten years.

The menopause treatment market is expected to reach US$ 22.9 Bn by the end of 2032.

An increased focus on reducing the adverse effects of therapy, novel drug launches, and government campaigns providing general awareness about menopause, are some of the key trends in this menopause treatment market.

The US, China, India, Japan, and Malaysia are the top five countries, which are expected to drive demand in the menopause treatment market.

The North American region is set to expand at a CAGR of 5.8% and holds a market share of about 21.4% by value in 2021 in the global menopause treatment market

Demand for menopause treatment in Europe is expected to register substantial growth as it generated nearly US$ 2.1 Billion in revenue in the global menopause treatment market in 2021.

China accounts for about 11.4% of the market share in 2021 in the global menopause treatment market.

East Asia region is growing with a CAGR of 5.7% with a market share of 22.2% in the global menopause treatment market in 2021.

India's menopause treatment market is expected to expand at a 5.9% CAGR over the forecast period.

Eli Lilly and Company, Merck KGaA, Novartis AG, Bayer AG, Pfizer, Inc., Novo Nordisk , Ascend Therapeutics, Mylan N.V. [Viatris], Cipla, Inc., Glenmark Pharmaceuticals Ltd., MenoGeniX, Perrigo Pharma International D.A.C., Ausio Pharmaceuticals, LLC, Endo Ceutics, Inc., and Radius Health, Inc. are the key players in the menopause treatment industry.

Table of Content

1. Executive Summary | Menopause Treatment Market

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage/Taxonomy

    2.2. Market Definition/Scope/Limitations

    2.3. Inclusion and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Development and Innovation Trends

4. Key Success Factors

    4.1. Product Adoption Analysis

    4.2. Recent Product Launches and Approvals

    4.3. Regulatory Scenario

    4.4. PESTLE Analysis

    4.5. Porter’s Analysis

    4.6. Supply Chain Analysis

    4.7. Key Strategies Adopted By Manufacturers

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Industry Outlook

        5.1.3. Global Menopause Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. R&D Expenditure of Pharmaceutical Companies

        5.2.2. Improvement in Healthcare Infrastructure

        5.2.3. Incidence of Vasomotor Symptoms

        5.2.4. Increase in Ageing Population

        5.2.5. Women's Health Campaigns

        5.2.6. Government Funding

        5.2.7. Product Recall

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Product

        6.1.2. By Route of Administration

        6.1.3. By Distribution Channel

        6.1.4. By Region

    6.2. 2021 Market Scenario

7. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032

    7.1. Historical Market Value (US$ Million) Analysis, 2017 to 2021

    7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Million) Analysis, By Product, 2017 to 2021

    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Product, 2022 to 2032

        8.3.1. Hormone Therapy

            8.3.1.1. Combination

            8.3.1.2. Tibolone

            8.3.1.3. Progestin-Only Medicines

            8.3.1.4. Estrogen-Only Medicines

        8.3.2. Non-Hormonal Therapy

            8.3.2.1. Gabapentinoids

            8.3.2.2. Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)

            8.3.2.3. Selective Serotonin Reuptake Inhibitors (SSRI)

            8.3.2.4. Others

    8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis By Route of Administration

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) Analysis, By Route of Administration, 2017 to 2021

    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Route of Administration, 2022 to 2032

        9.3.1. Topical

        9.3.2. Injectable

        9.3.3. Oral

    9.4. Market Attractiveness Analysis By Route of Administration

10. Global Market Analysis By Distribution Channel

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis, By Distribution Channel, 2017 to 2021

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Distribution Channel, 2022 to 2032

        10.3.1. Institutional Sales

            10.3.1.1. Hospitals

            10.3.1.2. Specialty Clinics

        10.3.2. Retail Sales

            10.3.2.1. Retail Pharmacies

            10.3.2.2. Drug Stores

            10.3.2.3. Supermarkets/ Hypermarkets

        10.3.3. Online Sales

    10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Market Analysis By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Million) Analysis, By Region, 2017 to 2021

    11.3. Current and Future Market Size (US$ Million) Analysis Forecast, By Region, 2022 to 2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis

    12.1. Introduction

    12.2. Historical Market Size (US$ Million) Trend Analysis, By Market Taxonomy, 2017 to 2021

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2022 to 2032

        12.3.1. By Country

            12.3.1.1. The US

            12.3.1.2. Canada

        12.3.2. By Product

        12.3.3. By Route of Administration

        12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Product

        12.4.3. By Route of Administration

        12.4.4. By Distribution Channel

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

    12.7. Key Market Trends

    12.8. Country-Level Analysis & Forecast

        12.8.1. The US Market Analysis

            12.8.1.1. Introduction

            12.8.1.2. Market Analysis and Forecast by Market Taxonomy

                12.8.1.2.1. By Product

                12.8.1.2.2. By Route of Administration

                12.8.1.2.3. By Distribution Channel

        12.8.2. Canada Market Analysis

            12.8.2.1. Introduction

            12.8.2.2. Market Analysis and Forecast by Market Taxonomy

                12.8.2.2.1. By Product

                12.8.2.2.2. By Route of Administration

                12.8.2.2.3. By Distribution Channel

13. Latin America Market Analysis

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    13.3. Current and Future Market Size (US$ Million) Analysis & Forecast By Market Taxonomy, 2022 to 2032

        13.3.1. By Country

            13.3.1.1. Brazil

            13.3.1.2. Argentina

            13.3.1.3. Mexico

            13.3.1.4. Rest of Latin America

        13.3.2. By Product

        13.3.3. By Route of Administration

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product

        13.4.3. By Route of Administration

        13.4.4. By Distribution Channel

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

    13.7. Key Market Trends

    13.8. Country-Level Analysis & Forecast

        13.8.1. Brazil Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast by Market Taxonomy

                13.8.1.2.1. By Product

                13.8.1.2.2. By Route of Administration

                13.8.1.2.3. By Distribution Channel

        13.8.2. Argentina Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast by Market Taxonomy

                13.8.2.2.1. By Product

                13.8.2.2.2. By Route of Administration

                13.8.2.2.3. By Distribution Channel

        13.8.3. Mexico Market Analysis

            13.8.3.1. Introduction

            13.8.3.2. Market Analysis and Forecast by Market Taxonomy

                13.8.3.2.1. By Product

                13.8.3.2.2. By Route of Administration

                13.8.3.2.3. By Distribution Channel

14. Europe Market Analysis

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. The UK

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Rest of Europe

        14.3.2. By Product

        14.3.3. By Route of Administration

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Route of Administration

        14.4.4. By Distribution Channel

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

    14.7. Key Market Trends

    14.8. Country-Level Analysis & Forecast

        14.8.1. Germany Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Product

                14.8.1.2.2. By Route of Administration

                14.8.1.2.3. By Distribution Channel

        14.8.2. France Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Product

                14.8.2.2.2. By Route of Administration

                14.8.2.2.3. By Distribution Channel

        14.8.3. Italy Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast by Market Taxonomy

                14.8.3.2.1. By Product

                14.8.3.2.2. By Route of Administration

                14.8.3.2.3. By Distribution Channel

        14.8.4. Spain Market Analysis

            14.8.4.1. Introduction

            14.8.4.2. Market Analysis and Forecast by Market Taxonomy

                14.8.4.2.1. By Product

                14.8.4.2.2. By Route of Administration

                14.8.4.2.3. By Distribution Channel

        14.8.5. The UK Market Analysis

            14.8.5.1. Introduction

            14.8.5.2. Market Analysis and Forecast by Market Taxonomy

                14.8.5.2.1. By Product

                14.8.5.2.2. By Route of Administration

                14.8.5.2.3. By Distribution Channel

        14.8.6. BENULUX Market Analysis

            14.8.6.1. Introduction

            14.8.6.2. Market Analysis and Forecast by Market Taxonomy

                14.8.6.2.1. By Product

                14.8.6.2.2. By Route of Administration

                14.8.6.2.3. By Distribution Channel

        14.8.7. Russia Market Analysis

            14.8.7.1. Introduction

            14.8.7.2. Market Analysis and Forecast by Market Taxonomy

                14.8.7.2.1. By Product

                14.8.7.2.2. By Route of Administration

                14.8.7.2.3. By Distribution Channel

15. South Asia Market Analysis

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Thailand

            15.3.1.3. Indonesia

            15.3.1.4. Malaysia

            15.3.1.5. Rest of South Asia

        15.3.2. By Product

        15.3.3. By Route of Administration

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Route of Administration

        15.4.4. By Distribution Channel

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

    15.7. Key Market Trends

    15.8. Country-Level Analysis & Forecast

        15.8.1. India Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Product

                15.8.1.2.2. By Route of Administration

                15.8.1.2.3. By Distribution Channel

        15.8.2. Indonesia Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Product

                15.8.2.2.2. By Route of Administration

                15.8.2.2.3. By Distribution Channel

        15.8.3. Malaysia Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Product

                15.8.3.2.2. By Route of Administration

                15.8.3.2.3. By Distribution Channel

        15.8.4. Thailand Market Analysis

            15.8.4.1. Introduction

            15.8.4.2. Market Analysis and Forecast by Market Taxonomy

                15.8.4.2.1. By Product

                15.8.4.2.2. By Route of Administration

                15.8.4.2.3. By Distribution Channel

16. East Asia Market Analysis

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Product

        16.3.3. By Route of Administration

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Route of Administration

        16.4.4. By Distribution Channel

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

    16.7. Key Market Trends

    16.8. Country-Level Analysis & Forecast

        16.8.1. China Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Product

                16.8.1.2.2. By Route of Administration

                16.8.1.2.3. By Distribution Channel

        16.8.2. Japan Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Product

                16.8.2.2.2. By Route of Administration

                16.8.2.2.3. By Distribution Channel

        16.8.3. South Korea Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Product

                16.8.3.2.2. By Route of Administration

                16.8.3.2.3. By Distribution Channel

17. Oceania Market Analysis

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Product

        17.3.3. By Route of Administration

        17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Route of Administration

        17.4.4. By Distribution Channel

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

    17.7. Key Market Trends

    17.8. Country-Level Analysis & Forecast

        17.8.1. Australia Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Product

                17.8.1.2.2. By Route of Administration

                17.8.1.2.3. By Distribution Channel

        17.8.2. New Zealand Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Product

                17.8.2.2.2. By Route of Administration

                17.8.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Market Analysis

    18.1. Introduction

    18.2. Historical Market Size (US$ Million Trend Analysis By Market Taxonomy, 2017 to 2021

    18.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Turkey

            18.3.1.3. North Africa

            18.3.1.4. South Africa

            18.3.1.5. Rest of Middle East and Africa

        18.3.2. By Product

        18.3.3. By Route of Administration

        18.3.4. By Distribution Channel

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Route of Administration

        18.4.4. By Distribution Channel

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

    18.7. Key Market Trends

    18.8. Country-Level Analysis & Forecast

        18.8.1. GCC Countries Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Product

                18.8.1.2.2. By Route of Administration

                18.8.1.2.3. By Distribution Channel

        18.8.2. Turkey Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Product

                18.8.2.2.2. By Route of Administration

                18.8.2.2.3. By Distribution Channel

        18.8.3. South Africa Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast by Market Taxonomy

                18.8.3.2.1. By Product

                18.8.3.2.2. By Route of Administration

                18.8.3.2.3. By Distribution Channel

        18.8.4. North Africa Market Analysis

            18.8.4.1. Introduction

            18.8.4.2. Market Analysis and Forecast by Market Taxonomy

                18.8.4.2.1. By Product

                18.8.4.2.2. By Route of Administration

                18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Share Analysis of Top Players

    19.3. Market Presence Analysis

        19.3.1. By Regional Footprint of Players

        19.3.2. By Product Footprint of Players

        19.3.3. By Channel Footprint of Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. Eli Lilly and Company

            20.3.1.1. Company Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Product Footprint

            20.3.1.4. Key Financials

            20.3.1.5. SWOT Analysis

            20.3.1.6. Key Developments

            20.3.1.7. Strategy Overview

                20.3.1.7.1. Product Strategy

                20.3.1.7.2. Channel Strategy

                20.3.1.7.3. Marketing Strategy

        20.3.2. Merck KGaA

            20.3.2.1. Company Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Product Footprint

            20.3.2.4. Key Financials

            20.3.2.5. SWOT Analysis

            20.3.2.6. Key Developments

            20.3.2.7. Strategy Overview

                20.3.2.7.1. Product Strategy

                20.3.2.7.2. Channel Strategy

                20.3.2.7.3. Marketing Strategy

        20.3.3. Novartis AG

            20.3.3.1. Company Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Product Footprint

            20.3.3.4. Key Financials

            20.3.3.5. SWOT Analysis

            20.3.3.6. Key Developments

            20.3.3.7. Strategy Overview

                20.3.3.7.1. Product Strategy

                20.3.3.7.2. Channel Strategy

                20.3.3.7.3. Marketing Strategy

        20.3.4. Bayer’s AG

            20.3.4.1. Company Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Product Footprint

            20.3.4.4. Key Financials

            20.3.4.5. SWOT Analysis

            20.3.4.6. Key Developments

            20.3.4.7. Strategy Overview

                20.3.4.7.1. Product Strategy

                20.3.4.7.2. Channel Strategy

                20.3.4.7.3. Marketing Strategy

        20.3.5. Pfizer, Inc.

            20.3.5.1. Company Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Product Footprint

            20.3.5.4. Key Financials

            20.3.5.5. SWOT Analysis

            20.3.5.6. Key Developments

            20.3.5.7. Strategy Overview

                20.3.5.7.1. Product Strategy

                20.3.5.7.2. Channel Strategy

                20.3.5.7.3. Marketing Strategy

        20.3.6. Novo Nordisk

            20.3.6.1. Company Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Product Footprint

            20.3.6.4. Key Financials

            20.3.6.5. SWOT Analysis

            20.3.6.6. Key Developments

            20.3.6.7. Strategy Overview

                20.3.6.7.1. Product Strategy

                20.3.6.7.2. Channel Strategy

                20.3.6.7.3. Marketing Strategy

        20.3.7. Ascend Therapeutics

            20.3.7.1. Company Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Product Footprint

            20.3.7.4. Key Financials

            20.3.7.5. SWOT Analysis

            20.3.7.6. Key Developments

            20.3.7.7. Strategy Overview

                20.3.7.7.1. Product Strategy

                20.3.7.7.2. Channel Strategy

                20.3.7.7.3. Marketing Strategy

        20.3.8. Mylan N.V. [Viatris]

            20.3.8.1. Company Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Product Footprint

            20.3.8.4. Key Financials

            20.3.8.5. SWOT Analysis

            20.3.8.6. Key Developments

            20.3.8.7. Strategy Overview

                20.3.8.7.1. Product Strategy

                20.3.8.7.2. Channel Strategy

                20.3.8.7.3. Marketing Strategy

        20.3.9. Cipla, Inc.

            20.3.9.1. Company Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Product Footprint

            20.3.9.4. Key Financials

            20.3.9.5. SWOT Analysis

            20.3.9.6. Key Developments

            20.3.9.7. Strategy Overview

                20.3.9.7.1. Product Strategy

                20.3.9.7.2. Channel Strategy

                20.3.9.7.3. Marketing Strategy

        20.3.10. Glenmark Pharmaceuticals Ltd.

            20.3.10.1. Company Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Product Footprint

            20.3.10.4. Key Financials

            20.3.10.5. SWOT Analysis

            20.3.10.6. Key Developments

            20.3.10.7. Strategy Overview

                20.3.10.7.1. Product Strategy

                20.3.10.7.2. Channel Strategy

                20.3.10.7.3. Marketing Strategy

        20.3.11. MenoGeniX

            20.3.11.1. Company Overview

            20.3.11.2. Product Portfolio

            20.3.11.3. Product Footprint

            20.3.11.4. Key Financials

            20.3.11.5. SWOT Analysis

            20.3.11.6. Key Developments

            20.3.11.7. Strategy Overview

                20.3.11.7.1. Product Strategy

                20.3.11.7.2. Channel Strategy

                20.3.11.7.3. Marketing Strategy

        20.3.12. Perrigo Pharma International D.A.C.

            20.3.12.1. Company Overview

            20.3.12.2. Product Portfolio

            20.3.12.3. Product Footprint

            20.3.12.4. Key Financials

            20.3.12.5. SWOT Analysis

            20.3.12.6. Key Developments

            20.3.12.7. Strategy Overview

                20.3.12.7.1. Product Strategy

                20.3.12.7.2. Channel Strategy

                20.3.12.7.3. Marketing Strategy

        20.3.13. Ausio Pharmaceuticals, LLC

            20.3.13.1. Company Overview

            20.3.13.2. Product Portfolio

            20.3.13.3. Product Footprint

            20.3.13.4. Key Financials

            20.3.13.5. SWOT Analysis

            20.3.13.6. Key Developments

            20.3.13.7. Strategy Overview

                20.3.13.7.1. Product Strategy

                20.3.13.7.2. Channel Strategy

                20.3.13.7.3. Marketing Strategy

        20.3.14. EndoCeutics, Inc.

            20.3.14.1. Company Overview

            20.3.14.2. Product Portfolio

            20.3.14.3. Product Footprint

            20.3.14.4. Key Financials

            20.3.14.5. SWOT Analysis

            20.3.14.6. Key Developments

            20.3.14.7. Strategy Overview

                20.3.14.7.1. Product Strategy

                20.3.14.7.2. Channel Strategy

                20.3.14.7.3. Marketing Strategy

        20.3.15. Radius Health, Inc.

            20.3.15.1. Company Overview

            20.3.15.2. Product Portfolio

            20.3.15.3. Product Footprint

            20.3.15.4. Key Financials

            20.3.15.5. SWOT Analysis

            20.3.15.6. Key Developments

            20.3.15.7. Strategy Overview

                20.3.15.7.1. Product Strategy

                20.3.15.7.2. Channel Strategy

                20.3.15.7.3. Marketing Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product

Table 02: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration

Table 03: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel

Table 04: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

Table 05: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

Table 06: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product

Table 07: North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration

Table 08: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel

Table 09: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

Table 10: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product

Table 11: Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration

Table 12: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel

Table 13: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

Table 14: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product

Table 15: Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration

Table 16: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel

Table 17: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

Table 18: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product

Table 19: East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration

Table 20: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel

Table 21: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

Table 22: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product

Table 23: South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032By Route of Administration

Table 24: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel

Table 25: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

Table 26: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product

Table 27: Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Route of Administration

Table 28: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel

Table 29: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

Table 30: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product

Table 31: Middle East & Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032 by Route of Administration

Table 32: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Value Analysis, 2017 to 2021

Figure 02: Global Market Forecast & Y-o-Y Growth, 2022 to 2032

Figure 03: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2021 to 2032

Figure 04: Global Market Value Share (%) Analysis 2022 and 2032, By Product

Figure 05: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By Product

Figure 06: Global Market Attractiveness Analysis 2022 to 2032, By Product

Figure 07: Global Market Value Share (%) Analysis 2022 and 2032, By Route of Administration

Figure 08: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By Route of Administration

Figure 09: Global Market Attractiveness Analysis 2022 to 2032, By Route of Administration

Figure 10: Global Market Value Share (%) Analysis 2022 and 2032, By Distribution Channel

Figure 11: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By Distribution Channel

Figure 12: Global Market Attractiveness Analysis 2022 to 2032, By Distribution Channel

Figure 13: Global Market Value Share (%) Analysis 2022 and 2032, By Region

Figure 14: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By Region

Figure 15: Global Market Attractiveness Analysis 2022 to 2032, By Region

Figure 16: North America Market Size (US$ Million) Analysis, 2022E & 2032F

Figure 17: North America Market Y-o-Y Analysis, 2022 to 2032

Figure 18: North America Market Value Analysis, 2017 to 2021

Figure 19: North America Market Forecast & Y-o-Y growth, 2022 to 2032

Figure 20: North America Market Value Share, By Product (2022 E)

Figure 21: North America Market Value Share, By Route of Administration (2022 E)

Figure 22: North America Market Value Share, By Distribution Channel (2022 E)

Figure 23: North America Market Value Share, By Country (2022 E)

Figure 24: North America Market Attractiveness Analysis by Product, 2022 to 2032

Figure 25: North America Market Attractiveness Analysis by Route of Administration, 2022 to 2032

Figure 26: North America Market Attractiveness Analysis by Distribution Channel, 2022 to 2032

Figure 27: North America Market Attractiveness Analysis by Country, 2022 to 2032

Figure 28: US Market Value Proportion Analysis, 2021

Figure 29: US Market Share Analysis (%) By Product, 2021 to 2032

Figure 30: US Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 31: US Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 32: Global Vs. US Growth Comparison

Figure 33: Canada Market Value Proportion Analysis, 2021

Figure 34: Canada Market Share Analysis (%) By Product, 2021 to 2032

Figure 35: Canada Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 36: Canada Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 37: Global Vs. Canada. Growth Comparison

Figure 38: Latin America Market Size (US$ Million) Analysis, 2022E & 2032F

Figure 39: Latin America Market Y-o-Y Analysis, 2022 to 2032

Figure 40: Latin America Market Value Analysis, 2017 to 2021

Figure 41: Latin America Market Forecast & Y-o-Y growth, 2022 to 2032

Figure 42: Latin America Market Value Share, By Product (2022 E)

Figure 43: Latin America Market Value Share, By Route of Administration (2022 E)

Figure 44: Latin America Market Value Share, By Distribution Channel (2022 E)

Figure 45: Latin America Market Value Share, By Country (2022 E)

Figure 46: Latin America Market Attractiveness Analysis by Product, 2022 to 2032

Figure 47: Latin America Market Attractiveness Analysis by Route of Administration, 2022 to 2032

Figure 48: Latin America Market Attractiveness Analysis by Distribution Channel, 2022 to 2032

Figure 49: Latin America Market Attractiveness Analysis by Country, 2022 to 2032

Figure 50: Mexico Market Value Proportion Analysis, 2021

Figure 51: Mexico Market Share Analysis (%) By Product, 2021 to 2032

Figure 52: Mexico Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 53: Mexico Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 54: Global Vs Mexico Growth Comparison

Figure 55: Brazil Market Value Proportion Analysis, 2021

Figure 56: Brazil Market Share Analysis (%) By Product, 2021 to 2032

Figure 57: Brazil Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 58: Brazil Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 59: Global Vs. Brazil. Growth Comparison

Figure 60: Argentina Market Value Proportion Analysis, 2021

Figure 61: Argentina Market Share Analysis (%) By Product, 2021 to 2032

Figure 62: Argentina Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 63: Argentina Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 64: Global Vs Argentina Growth Comparison

Figure 65: Europe Market Size (US$ Million) Analysis, 2022E & 2032F

Figure 66: Europe Market Y-o-Y Analysis, 2022 to 2032

Figure 67: Europe Market Value Analysis, 2017 to 2021

Figure 68: Europe Market Forecast & Y-o-Y growth, 2022 to 2032

Figure 69: Europe Market Value Share, By Product (2022 E)

Figure 70: Europe Market Value Share, By Route of Administration (2022 E)

Figure 71: Europe Market Value Share, By Distribution Channel (2022 E)

Figure 72: Europe Market Value Share, By Country (2022 E)

Figure 73: Europe Market Attractiveness Analysis by Product, 2022 to 2032

Figure 74: Europe Market Attractiveness Analysis by Route of Administration, 2022 to 2032

Figure 75: Europe Market Attractiveness Analysis by Distribution Channel, 2022 to 2032

Figure 76: Europe Market Attractiveness Analysis by Country, 2022 to 2032

Figure 77: UK. Market Value Proportion Analysis, 2021

Figure 78: UK. Market Share Analysis (%) By Product, 2021 to 2032

Figure 79: UK. Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 80: UK. Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 81: Global Vs. UK Growth Comparison

Figure 82: Germany Market Value Proportion Analysis, 2021

Figure 83: Germany Market Share Analysis (%) By Product, 2021 to 2032

Figure 84: Germany Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 85: Germany Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 86: Global Vs. Germany Growth Comparison

Figure 87: Italy Market Value Proportion Analysis, 2021

Figure 88: Italy Market Share Analysis (%) By Product, 2021 to 2032

Figure 89: Italy Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 90: Italy Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 91: Global Vs. Italy Growth Comparison

Figure 92: France Market Value Proportion Analysis, 2021

Figure 93: France Market Share Analysis (%) By Product, 2021 to 2032

Figure 94: France Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 95: France Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 96: Global Vs France Growth Comparison

Figure 97: Spain Market Value Proportion Analysis, 2021

Figure 98: Spain Market Share Analysis (%) By Product, 2021 to 2032

Figure 99: Spain Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 100: Spain Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 101: Global Vs Spain Growth Comparison

Figure 102: Russia Market Value Proportion Analysis, 2021

Figure 103: Russia Market Share Analysis (%) By Product, 2021 to 2032

Figure 104: Russia Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 105: Russia Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 106: Global Vs Russia Growth Comparison

Figure 107: BENELUX Market Value Proportion Analysis, 2021

Figure 108: BENELUX Market Share Analysis (%) By Product, 2021 to 2032

Figure 109: BENELUX Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 110: BENELUX Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 111: Global Vs BENELUX Growth Comparison

Figure 112: East Asia Market Size (US$ Million) Analysis, 2022E & 2032F

Figure 113: East Asia Market Y-o-Y Analysis, 2022 to 2032

Figure 114: East Asia Market Value Analysis, 2017 to 2021

Figure 115: East Asia Market Forecast & Y-o-Y growth, 2022 to 2032

Figure 116: East Asia Market Value Share, By Product (2022 E)

Figure 117: East Asia Market Value Share, By Route of Administration (2022 E)

Figure 118: East Asia Market Value Share, By Distribution Channel (2022 E)

Figure 119: East Asia Market Value Share, By Country (2022 E)

Figure 120: East Asia Market Attractiveness Analysis by Product, 2022 to 2032

Figure 121: East Asia Market Attractiveness Analysis by Route of Administration, 2022 to 2032

Figure 122: East Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2032

Figure 123: East Asia Market Attractiveness Analysis by Country, 2022 to 2032

Figure 124: China Market Value Proportion Analysis, 2021

Figure 125: China Market Share Analysis (%) By Product, 2021 to 2032

Figure 126: China Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 127: China Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 128: Global Vs. China Growth Comparison

Figure 129: Japan Market Value Proportion Analysis, 2021

Figure 130: Japan Market Share Analysis (%) By Product, 2021 to 2032

Figure 131: Japan Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 132: Japan Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 133: Global Vs. Japan Growth Comparison

Figure 134: South Korea Market Value Proportion Analysis, 2021

Figure 135: South Korea Market Share Analysis (%) By Product, 2021 to 2032

Figure 136: South Korea Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 137: South Korea Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 138: Global Vs South Korea Growth Comparison

Figure 139: South Asia Market Size (US$ Million) Analysis, 2022E & 2032F

Figure 140: South Asia Market Y-o-Y Analysis, 2022 to 2032

Figure 141: South Asia Market Value Analysis, 2017 to 2021

Figure 142: South Asia Market Forecast & Y-o-Y growth, 2022 to 2032

Figure 143: South Asia Market Value Share, By Product (2022 E)

Figure 144: South Asia Market Value Share, By Route of Administration (2022 E)

Figure 145: South Asia Market Value Share, By Distribution Channel (2022 E)

Figure 146: South Asia Market Value Share, By Country (2022 E)

Figure 147: South Asia Market Attractiveness Analysis by Product, 2022 to 2032

Figure 148: South Asia Market Attractiveness Analysis by Route of Administration, 2022 to 2032

Figure 149: South Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2032

Figure 150: South Asia Market Attractiveness Analysis by Country, 2022 to 2032

Figure 151: India Market Value Proportion Analysis, 2021

Figure 152: India Market Share Analysis (%) By Product, 2021 to 2032

Figure 153: India Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 154: India Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 155: Global Vs. India Growth Comparison

Figure 156: Indonesia Market Value Proportion Analysis, 2021

Figure 157: Indonesia Market Share Analysis (%) By Product, 2021 to 2032

Figure 158: Indonesia Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 159: Indonesia Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 160: Global Vs. Indonesia Growth Comparison

Figure 161: Malaysia Market Value Proportion Analysis, 2021

Figure 162: Malaysia Market Share Analysis (%) By Product, 2021 to 2032

Figure 163: Malaysia Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 164: Malaysia Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 165: Global Vs. Malaysia Growth Comparison

Figure 166: Thailand Market Value Proportion Analysis, 2021

Figure 167: Thailand Market Share Analysis (%) By Product, 2021 to 2032

Figure 168: Thailand Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 169: Thailand Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 170: Global Vs. Thailand Growth Comparison

Figure 171: Oceania Market Size (US$ Million) Analysis, 2022E & 2032F

Figure 172: Oceania Market Y-o-Y Analysis, 2022 to 2032

Figure 173: Oceania Market Value Analysis, 2017 to 2021

Figure 174: Oceania Market Forecast & Y-o-Y growth, 2022 to 2032

Figure 175: Oceania Market Value Share, By Product (2022 E)

Figure 176: Oceania Market Value Share, By Route of Administration (2022 E)

Figure 177: Oceania Market Value Share, By Distribution Channel (2022 E)

Figure 178: Oceania Market Value Share, By Country (2022 E)

Figure 179: Oceania Market Attractiveness Analysis by Product, 2022 to 2032

Figure 180: Oceania Market Attractiveness Analysis by Route of Administration, 2022 to 2032

Figure 181: Oceania Market Attractiveness Analysis by Distribution Channel, 2022 to 2032

Figure 182: Oceania Market Attractiveness Analysis by Country, 2022 to 2032

Figure 183: Australia Market Value Proportion Analysis, 2021

Figure 184: Australia Market Share Analysis (%) By Product, 2021 to 2032

Figure 185: Australia Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 186: Australia Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 187: Global Vs. Australia Growth Comparison

Figure 188: New Zealand Market Value Proportion Analysis, 2021

Figure 189: New Zealand Market Share Analysis (%) By Product, 2021 to 2032

Figure 190: New Zealand Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 191: New Zealand Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 192: Global Vs New Zealand Growth Comparison

Figure 193: Middle East & Africa Market Size (US$ Million) Analysis, 2022E & 2032F

Figure 194: Middle East & Africa Market Y-o-Y Analysis, 2022 to 2032

Figure 195: Middle East & Africa Market Value Analysis, 2017 to 2021

Figure 196: Middle East & Africa Market Forecast & Y-o-Y growth, 2022 to 2032

Figure 197: Middle East & Africa Market Value Share, By Product (2022 E)

Figure 198: Middle East & Africa Market Value Share, By Route of Administration (2022 E)

Figure 199: Middle East & Africa Market Value Share, By Distribution Channel (2022 E)

Figure 200: Middle East & Africa Market Value Share, By Country (2022 E)

Figure 201: Middle East & Africa Market Attractiveness Analysis by Product, 2022 to 2032

Figure 202: Middle East & Africa Market Attractiveness Analysis by Route of Administration, 2022 to 2032

Figure 203: Middle East & Africa Market Attractiveness Analysis by Distribution Channel, 2022 to 2032

Figure 204: Middle East & Africa Market Attractiveness Analysis by Country, 2022 to 2032

Figure 205: GCC Countries Market Value Proportion Analysis, 2021

Figure 206: GCC Countries Market Share Analysis (%) By Product, 2021 to 2032

Figure 207: GCC Countries Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 208: GCC Countries Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 209: Global Vs GCC Countries Growth Comparison

Figure 210: Turkey Market Value Proportion Analysis, 2021

Figure 211: Turkey Market Share Analysis (%) By Product, 2021 to 2032

Figure 212: Turkey Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 213: Turkey Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 214: Global Vs. Turkey Growth Comparison

Figure 215: South Africa Market Value Proportion Analysis, 2021

Figure 216: South Africa Market Share Analysis (%) By Product, 2021 to 2032

Figure 217: South Africa Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 218: South Africa Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 219: Global Vs. South Africa Growth Comparison

Figure 220: North Africa Market Value Proportion Analysis, 2021

Figure 221: North Africa Market Share Analysis (%) By Product, 2021 to 2032

Figure 222: North Africa Market Share Analysis (%) By Route of Administration, 2021 to 2032

Figure 223: North Africa Market Share Analysis (%) By Distribution Channel, 2021 to 2032

Figure 224: Global Vs North Africa Growth Comparison

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Human Growth Hormone Treatment & Drugs Market

Published : March 2022

Healthcare

Hormone Replacement Therapy Market

Published : May 2017

Healthcare

Thyroid Function Tests Market

Published : January 1970

Google translate

Menopause Treatment Market